Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
TB-500 adds angiogenic, actin-control, and ILK-start signals while BPC-157 adds gut cytoprotective, tendon fibroblast, and systemic NO-pathway effects
Topical GHK-Cu application: Topical formulations sidestep syringe selection entirely, but they require a minimum peptide concentration of 0.1 to 1% by weight to penetrate the stratum corneum
You also shouldnt shave the treated area after treatment until it has fully healed
We're here to provide the support and advanced therapies you need to truly thrive
Mixing GHK-Cu with BPC-157 in the same syringe, if running a broader protocol, also reduces injection site irritation per reported user experience
For the broader category context on multi-mechanism metabolic peptides, see Triple Agonist Peptides Explained: Retatrutide, GLP-3, and the Future of Metabolic Research
